These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 13726755)

  • 1. Corticosteroid release and synthesis in vitro by adrenal slices from patients with Cushing's syndrome.
    MULROW PJ; COHN GL
    J Clin Invest; 1961 Jul; 40(7):1250-62. PubMed ID: 13726755
    [No Abstract]   [Full Text] [Related]  

  • 2. An attempt to inhibit synthesis of corticosteroid hormones by means of diethylstilboestrol in a case of Cushing's syndrome. Preliminary report.
    KOVACIC N
    Acta Med Scand; 1959 Aug; 164():455-61. PubMed ID: 14411382
    [No Abstract]   [Full Text] [Related]  

  • 3. [Data on the biogensis of steroids in a perfusion experiment on the surviving adrenal gland of a patient with Cushing's syndrome].
    KORUS W; SCHRIEFERS H; BREUER H; BAYER JM
    Acta Endocrinol (Copenh); 1959 Aug; 31():529-41. PubMed ID: 14411153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Characteristics of steroidogenesis and metabolism of corticosteroids in different forms of Cushing's disease].
    Cristoveanu A; Ciobanu D; Berceanu A; Stan M
    Stud Cercet Endocrinol; 1966; 17(3):257-68. PubMed ID: 4287864
    [No Abstract]   [Full Text] [Related]  

  • 5. [Corticoadrenal pathology in Cushing's syndrome].
    Simionescu N
    Stud Cercet Endocrinol; 1968; 19(2):93-101. PubMed ID: 5669248
    [No Abstract]   [Full Text] [Related]  

  • 6. METABOLISM OF CORTISOL BY THE HUMAN ADRENAL CORTEX IN VITRO.
    JENKINS JS
    J Clin Endocrinol Metab; 1965 May; 25():649-54. PubMed ID: 14313759
    [No Abstract]   [Full Text] [Related]  

  • 7. [Aspects of the metabolism of cortisol and cortexolone (or of compound S) in the normal condition and in Cushing's disease].
    Hoet JJ; de Hertogh R; Coupez-Lopinot R; Libert R; Ekka E
    Ann Endocrinol (Paris); 1968; 29(1):3-4. PubMed ID: 4297999
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in corticosteroid synthesis of the human adrenal cortex in vitro, induced by treatment with o,p'-DDD for Cushing's syndrome: evidence for the sites of action of the drug.
    Touitou Y; Bogdan A; Luton JP
    J Steroid Biochem; 1978 Dec; 9(12):1217-24. PubMed ID: 745418
    [No Abstract]   [Full Text] [Related]  

  • 9. METABOLISM OF PROGESTERONE-4-14C BY ADRENAL TISSUE FROM A PATIENT WITH CUSHING'S SYNDROME.
    ADADEVOH BK; ENGEL LL; SHAW D; GRAY CH
    J Clin Endocrinol Metab; 1965 Jun; 25():784-91. PubMed ID: 14296263
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological treatment of hypercortisolism.
    Shalet S; Mukherjee A
    Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):234-8. PubMed ID: 18438170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical response to dexamethasone-suppression in Cushing's disease with adrenal hyperplasia.
    Winkler G; Huhnstock K; Graef V
    Rass Neurol Veg; 1969; 23(5):187-93. PubMed ID: 4328312
    [No Abstract]   [Full Text] [Related]  

  • 12. [The diagnosis of Cushing's syndrome. Results of diagnostic assessment of 20 patients with Cushing's syndrome of variable etiology (1979-1989)].
    Caduff F; Staub JJ; Nordmann A; Radü EW; Landolt H
    Schweiz Med Wochenschr; 1991 Jan; 121(1-2):10-20. PubMed ID: 1990418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 17-hydroxycorticosteroids in Cushing's syndrome.
    EKMAN H; HAKANSSON B; McARTHY JD; LEHMANN J; SJOGREN B
    J Clin Endocrinol Metab; 1961 Jun; 21():684-94. PubMed ID: 13726263
    [No Abstract]   [Full Text] [Related]  

  • 14. Cushing's syndrome from Klack's solution.
    Lankford HV
    Endocr Pract; 2000; 6(6):456-8. PubMed ID: 11155219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation and suppression of the adrenal cortex in Cushing's syndrome.
    NABARRO JD; MOXHAM A; WALKER G
    J Clin Endocrinol Metab; 1958 Jun; 18(6):586-99. PubMed ID: 13539171
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical corticosteroid therapy in Cushing's syndrome].
    Haim S; Zamir B; Dickstein G; Barzilai D
    Harefuah; 1981 Nov; 101(9):216. PubMed ID: 7347301
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of dexamethasone suppression test to indicate bilateral adrenocortical hyperplasia in Cushing's syndrome.
    SILVERMAN SR; MARNELL RT; SHOLITON LJ; WERK EE
    J Clin Endocrinol Metab; 1963 Feb; 23():167-72. PubMed ID: 13992947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Functional state of the myocardium in Itsenko-Cushing's syndrome].
    Ar'eva LP
    Ter Arkh; 1971 May; 43(5):46-50. PubMed ID: 5117929
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term outcome of bilateral adrenalectomy in patients with Cushing's syndrome.
    O'Riordain DS; Farley DR; Young WF; Grant CS; van Heerden JA
    Surgery; 1994 Dec; 116(6):1088-93; discussion 1093-4. PubMed ID: 7985092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SOME ASPECTS OF STEROID FORMATION IN CUSHING'S SYNDROME. TESTS MADE WITH ACETATE-2-C14].
    JACOBELLI A; PICCARDO MG; DONATI L; LUZIETTI L; RONCELLA A
    Minerva Nucl; 1963 Oct; 7():383-5. PubMed ID: 14119614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.